Hospitalized community-acquired pneumonia in the elderly: an Australian case-cohort study

被引:24
作者
Skull, S. A. [1 ,2 ,3 ]
Andrews, R. M. [1 ]
Byrnes, G. B. [4 ]
Campbell, D. A. [5 ]
Kelly, H. A. [6 ]
Brown, G. V. [7 ,8 ]
Nolan, T. M. [3 ]
机构
[1] Menzies Sch Hlth Res, Casuarina, NT 0810, Australia
[2] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia
[3] Murdoch Childrens Res Inst, Parkville, Vic, Australia
[4] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia
[5] Monash Med Ctr, Monash Inst Hlth Serv Res, Clayton, Vic 3168, Australia
[6] Victorian Infect Dis Reference Lab, Melbourne, Australia
[7] Univ Melbourne, Royal Melbourne Hosp, Nossal Inst Global Hlth, Dept Med, Parkville, Vic, Australia
[8] Univ Melbourne, Royal Melbourne Hosp, Ctr Clin Res Excellence Infect Dis, Parkville, Vic, Australia
基金
英国医学研究理事会;
关键词
PNEUMOCOCCAL VACCINE; POPULATION; ETIOLOGY; DEATH; RISK; AGE;
D O I
10.1017/S0950268808000812
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This study describes the epidemiology of community-acquired pneumonia (CAP) in elderly Australians for the first time. Using a case-cohort design, cases with CAP were in-patients aged >= 65 years with ICD-10-AM codes J10-J18 admitted over 2 years to two tertiary hospitals. The cohort sample was randomly selected from all hospital discharges, frequency-matched to cases by month. Logistic regression was used to estimate risk ratios for factors predicting CAP or associated mortality. A total of 4772 in-patients were studied. There were 1952 cases with CAP that represented 40% of all elderly admissions: mean length of stay was 9.0 days and 30-day mortality was 18%. Excluding chest radiograph, 520/1864 (28%) cases had no investigations performed. The strongest predictors of CAP were previous pneumonia, history of other respiratory disease, and aspiration. Intensive-care-unit admission, renal disease and increasing age were the strongest predictors of mortality, while influenza vaccination conferred protection. Hospitalization with CAP in the elderly is common, frequently fatal and a considerable burden to the Australian community. Investigation is ad hoc and management empirical. Influenza vaccination is associated with reduced mortality. Patient characteristics can predict risk of CAP and subsequent mortality.
引用
收藏
页码:194 / 202
页数:9
相关论文
共 50 条
  • [41] Rates and Risk Factors for Recurrent Pneumonia in Patients Hospitalized With Community-Acquired Pneumonia: Population-Based Prospective Cohort Study With 5 Years of Follow-up
    Dang, T. T.
    Eurich, D. T.
    Weir, D. L.
    Marrie, T. J.
    Majumdar, S. R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (01) : 74 - 80
  • [42] Systemic cytokines and chemokines on admission of children hospitalized with community-acquired pneumonia
    Vasconcellos, Angela G.
    Clarencio, Jorge
    Andrade, Daniela
    Cardoso, Maria-Regina A.
    Barral, Aldina
    Nascimento-Carvalho, Cristiana M.
    [J]. CYTOKINE, 2018, 107 : 1 - 8
  • [43] Aetiology and risk factors of community-acquired pneumonia in hospitalized patients in Norway
    Roysted, Wenche
    Simonsen, Oystein
    Jenkins, Andrew
    Sarjomaa, Marjut
    Svendsen, Martin Veel
    Ragnhildstveit, Eivind
    Tveten, Yngvar
    Kanestrom, Anita
    Waage, Halfrid
    Ringstad, Jetmund
    [J]. CLINICAL RESPIRATORY JOURNAL, 2016, 10 (06) : 756 - 764
  • [44] Diagnosis of Community-acquired Pneumonia in Hospitalized Children: A Multicenter Experience in Bolivia
    Perales, Jose Gareca
    Ortiz, Lorena Soleto
    Mafayle, Roxana Loayza
    Soto, Blanca Machuca
    Flores, Lucia Hidalgo
    Montano, Javier Lopez
    Calle, Neida Zuna
    Jarovsky, Daniel
    Berezin, Eitan Naaman
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (01) : 32 - 38
  • [45] Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia
    Goldstein, Lee Hilary
    Gabin, Ahmad
    Fawaz, Abdallah
    Freedberg, Nahum Adam
    Schwartz, Naama
    Elias, Mazen
    Saliba, Walid
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (10) : 1042 - 1048
  • [46] Role of Chlamydia pneumoniae in community-acquired pneumonia in hospitalized Jordanian adults
    Al-Aydie, Suzan N.
    Obeidat, Nathir M.
    Al-Younes, Hesham M.
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2016, 10 (03): : 227 - 236
  • [47] Early and Late Cardiovascular Events in Patients Hospitalized for Community-Acquired Pneumonia
    Aldas, Irene
    Menendez, Rosario
    Mendez, Raul
    Pablo Espana, Pedro
    Almirall, Jordi
    Boderias, Luis
    Rajas, Olga
    Zalacain, Rafael
    Vendrell, Montserrat
    Mir, Isabel
    Torres, Antoni
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (09): : 551 - 558
  • [48] Long-term Mortality in Hospitalized Patients With Community-Acquired Pneumonia
    Peyrani, Paula
    Ramirez, Julio
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 353 (05) : 421 - 421
  • [49] Clinical profile of children with and without comorbidities hospitalized with community-acquired pneumonia
    Aurilio, Rafaela Baroni
    Sant'Anna, Clemax Couto
    Bazhuni Pombo March, Maria de Fatima
    [J]. REVISTA PAULISTA DE PEDIATRIA, 2020, 38
  • [50] Short-course antibiotic therapy for hospitalized patients with early clinical response in community-acquired pneumonia: a multicentre cohort study
    Israelsen, Simone Bastrup
    Fally, Markus
    Tarp, Britta
    Kolte, Lilian
    Ravn, Pernille
    Benfield, Thomas
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (01) : 54 - 60